The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis

Experimental and Clinical Cardiology

Volumn 13, Issue 4, 2008, Pages 183-188

  Yucel, Tuba ^a   Memiş, Dilek ^a   Karamanlioglu, Beyhan ^a   Süt, Necdet ^a   Yuksel, Mahmut ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Intensive care unit; Natriuretic peptides; Prognosis; Sepsis; Troponin I

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN I;

ADULT; AGED; APACHE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; MORTALITY; PREDICTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEPSIS; SURVIVAL;

EID: 63449126664     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-88.
2. Clerico A. Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: Are they merely markers of cardiac disease? Clin Chem Lab Med 2002;40:752-60.
3. Hall C, Rouleau JL, Moyé L, et al. N-terminal proatrial natriuretic factor: An independent predictor of long-term prognosis after myocardial infarction. Circulation 1994;89:1934-42.
4. Gottlieb S, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:153-9.
5. Mitaka C, Nagura T, Sakanishi N, Tsunoda Y, Toyooka H. Plasma alpha-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: Preliminary study. Crit Care Med 1990;18:1201-3.
6. Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;313:757-8.
7. Witthaut R, Busch C, Fraunberger P, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003;29:1696-702.
8. Price S, Anning SB, Mitchell JA, Evans TW. Myocardial dysfunction in sepsis: Mechanisms and therapeutic implications. Eur Heart J 1999;20:715-24.
9. Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999;27:1775-80.
10. Ammann P, Fehr T, Minder EI, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001;27:965-9.
11. Adams JE 3rd, Bodor GS, Davila-Roman VG, et al. Cardiac troponin-I. A marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
12. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
13. Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 1995;273:1945-9.
14. Marty C, Misset B, Tamion F, et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-9.
15. Roumen RM, Redl H, Schlag G, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-80.
16. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995;21(Suppl 2):S258-S63.
17. Póvoa P, Almeida E, Moreira P, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998;24:1052-6.
18. Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995;21:602-5.
19. Smith RP, Lipworth BJ, Cree IA, et al. C-reactive protein: A clinical marker in community-acquired pneumonia. Chest 1995;108:1288-91.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
21. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
23. Angus,DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
24. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
25. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003;112:460-7.
26. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003;9:517-24.
27. Maeder M, Fehr T, Rickli H, Amman P. Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006;129:1349-66.
28. Hartemink KJ, Groeneveld AB, de Groot MC, et al. Alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med 2001;29:80-7.
29. Mazul-Sunko B, Zarkovic N, Vrkic N, et al. Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients. J Endocrinol Invest 2001;24:RC22-RC4.
30. Mitaka C, Hirata Y, Makita K, et al. Endothelin-1 and atrial natriuretic peptide in septic shock. Am Heart J 1993;126:466-8.
31. Witthaut R, Busch C, Fraunberger P, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interteukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003;29:1696-702.
32. Charpentier J, Luyt CE, Fulla Y, et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004;32:660-5.
33. Cuthbertson BH, Patel RR, Croal BL, et al. B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 2005;60:16-21.
34. Tung RH, Garcia C, Morss AM, et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004;32:1643-7.
35. Forfia PR, Watkins SP, Rame JE, et al. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005;45:1667-71.
36. Jefic D, Lee JW, Jefic D, et al. Utility of B-type natriuretic peptide an N-terminal Pro B-type nariuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 2005;128:288-95.
37. Berendes E, Van Aken H, Raufhake C, et al. Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 2001;93:676-82.
38. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST-elevation acute coronary syndromes: A meta-analysis. J Am Coll Cardiol 2001;38:478-85.
39. Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients: A frequently unrecognized complication. JAMA 1995;273:1945-9.
40. Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999;27:1775-80.
41. Arlati S, Brenna S, Prencipe L, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: A prospective study. Intensive Care Med 2000;26:31-7.
42. Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001;27:965-9.
43. Ver Elst KM, Spapen HD, Nguyen DN, et al. Cardiac troponin I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000;46:650-7.
44. Metha NJ, Khan IA, Gupta V, et al. Cardiac troponin predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004;95:13-7.
45. Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41;2004-9.
46. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol 1996;156:4815-20.
47. Presterl E, Staudinger T, Pettermann M, et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997;156:825-32.
48. Eichacker PQ, Parent C, Kalil A, et al. Risk and the efficacy of antiinflammatory agents: Retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 2002;166:1197-205.